Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Ankon Medical Technologies

Health Tech & Medtech · Wuhan, China · Founded 2009 Unicorn

Develops medical equipment for gastric diagnosis

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

1 investor on Ankon Medical Technologies's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage
SB China Capital

Global footprint

Where Ankon Medical Technologies has talent and traffic

Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown
Web traffic by country
6.2K monthly visits
across markets
🇨🇳 China100%
Top 1 markets shown

Patent intelligence

$56M patent portfolio · 411 active families

Estimated portfolio value
$56M
5.6% of valuation · 53.8× smaller than top peer Intuitive Surgical ($3B)
411 active patent families
Where Ankon Medical Technologies innovates Capsule EndoscopesMechanical engineeringPhysicsEndoscopyBiomedical engineering

Where Ankon Medical Technologies concentrates vs peers

Each axis is a top-10 topic across Ankon Medical Technologies and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Ankon Medical Technologies

An AI-synthesized read of the highest-engagement posts about Ankon Medical Technologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ankon Medical Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.